Evidence map›Paper›PMID 34471460›Full record

ArticleThe World Allergy Organization journal2021

"Chronic urticaria and obstructive sleep apnea: Is there a significant association?"

Ivan Cherrez-Ojeda, Marcus Maurer, Miguel Felix, Jonathan A Bernstein, German D Ramon, Roberta Fachini Jardim Criado, Valeria L Mata, Annia Cherrez, Blanca María Morfin-Maciel, José Ignacio Larco and 9 more

Abstract read
In one paragraph

Article in The World Allergy Organization journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ivan Cherrez-OjedaUniversidad Espíritu Santo, Samborondón, Ecuador.
Marcus MaurerDermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany.
Miguel FelixUniversidad Espíritu Santo, Samborondón, Ecuador.
Jonathan A BernsteinUniversity of Cincinnati College of Medicine, Department of Internal Medicine, Division of Immunology/Allergy Section, Cincinnati, OH, United States.
German D RamonInstituto de Alergia e Inmunología del Sur, Bahía Blanca, Argentina.
Roberta Fachini Jardim CriadoDepartment of Dermatology, Faculdade de Medicina do ABC, São Paulo, Brazil.
Valeria L MataUniversidad Espíritu Santo, Samborondón, Ecuador.
Annia CherrezRespiralab, Respiralab Research Group, Guayaquil, Ecuador.
Blanca María Morfin-MacielHospital San Angel Inn Chapultepec, Ciudad de Mexico, Mexico.
José Ignacio LarcoAllergy Department, Clinica San Felipe, Lima, Peru.
Iván O TinocoCentro de Alergia Tinoco, Machala, Ecuador.
Gonzalo Federico ChorzepaSanatorio Parque, Rosario, Argentina.
René Maximiliano GómezFundación Ayre at Instituto Médico Alas, Salta, Argentina.
Rodolfo Jaller RaadDepartamento de Alergias del Centro de Asma Alergia e Inmunología Barranquilla, Colombia.
Simon Francis ThomsenDepartment of Dermatology, Bispebjerg Hospital and Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Peter Schmid-GrendelmeierAllergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Carole GuilletAllergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Sofia CherrezRespiralab, Respiralab Research Group, Guayaquil, Ecuador.
Emanuel VanegasUniversidad Espíritu Santo, Samborondón, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFew studies have explored the association between obstructive sleep apnea (OSA) and chronic urticaria (CU). Our study aims to fill this gap by determining the frequency of the risk categories for OSA and how they might correlate with the specific CU patient reported outcome measures urticaria activity score (UAS7), urticaria control test (UCT) and CU quality of life questionnaire (CU-Q2oL).

methodsWe conducted a cross-sectional study involving a cohort of 171 Latin American CU patients. Descriptive statistics were used to determine frequency and proportions for demographic and clinical variables, while a chi-squared test for association between STOP-Bang OSA questionnaire categories and both UAS7 and UCT categories was performed to analyze how such variables interact. To further assess the strength of the correlation a Cramer's V coefficient was reported. Finally, a Kendall-Tau b correlation coefficient was performed to measure the correlation between the STOP-Bang score and other independent continuous variables.

resultsThe average STOP-Bang score was 2.5, with 24% and 21% of patients falling into the intermediate and high-risk category for moderate-to-severe OSA, respectively. There was a strong statistically significant association (Cramer's V = 0.263; p = .000) between UAS-7 categories and STOP-Bang risk categories

conclusionsOur results suggest that a considerable proportion of patients with CU are at intermediate to high risk for OSA. Higher disease activity, poor CU control, and worse quality of life were all found to be associated with an increased risk. Additional studies are needed to determine the exact link between these conditions, and to determine whether screening and treatment for OSA might benefit patients with CU.

Indexed as

Chronic urticariaQuality of lifeSleep apnea

Identifiers

PMID34471460
PMCPMC8387911

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.